Zobrazeno 1 - 10
of 1 019
pro vyhledávání: '"James L Gulley"'
Autor:
Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins, Wiem Lassoued, Kenneth Canubas, Andrew Warner, Baktiar Karim, Ksenia Vulikh, James W. Hodge, Charalampos S. Floudas, James L. Gulley, Gary L. Gallia, Clint T. Allen, Nyall R. London
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-16 (2024)
Abstract Background Olfactory neuroblastoma is a rare malignancy of the anterior skull base typically treated with surgery and adjuvant radiation. Although outcomes are fair for low-grade disease, patients with high-grade, recurrent, or metastatic di
Externí odkaz:
https://doaj.org/article/9c3008c5e18e402ebfcaa48b6b269fbc
Autor:
Renee N Donahue, Jeffrey Schlom, James L Gulley, James W Hodge, Claudia Palena, Duane H Hamilton, Sofia R Gameiro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
The development of vaccines, especially RNA-based, directed against patient-specific tumor neoepitopes is an active and productive area of cancer immunotherapy. Promising clinical results in melanoma and other solid tumor types are emerging. As with
Externí odkaz:
https://doaj.org/article/a0dfb2ad06104e178521dabe0f22daa7
Autor:
James L Gulley, Deborah Collyar, Pedro J Romero, Christian M Capitini, Leisha A Emens, Avery D Posey, Patrick Hwu, Jennifer A Wargo, Ann W Silk, Ana Carrizosa Anderson, Tullia C Bruno
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Cancer immunotherapy has flourished over the last 10–15 years, transforming the practice of oncology and providing long-term clinical benefit to some patients. During this time, three distinct classes of immune checkpoint inhibitors, chimeric antig
Externí odkaz:
https://doaj.org/article/ba0feaa1364741509df21dfe108b7d2c
Autor:
Elisabetta Xue, Dara Bracken-Clarke, Giovanni Maria Iannantuono, Hyoyoung Choo-Wosoba, James L Gulley, Charalampos S Floudas
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e54758 (2024)
BackgroundArtificial intelligence is increasingly being applied to many workflows. Large language models (LLMs) are publicly accessible platforms trained to understand, interact with, and produce human-readable text; their ability to deliver relevant
Externí odkaz:
https://doaj.org/article/054ce0b02e38414481ffc34088368d42
Autor:
Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins, Wiem Lassoued, Kenneth Canubas, Andrew Warner, Baktiar Karim, Ksenia Vulikh, James W. Hodge, Charalampos S. Floudas, James L. Gulley, Gary L. Gallia, Clint T. Allen, Nyall R. London
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/7d7eee268c504f4a856af0a3556c3ff0
Autor:
Diana C. Lopez, Kellsye P. Fabian, Michelle R. Padget, Yvette L. Robbins, Joshua T. Kowalczyk, Wiem Lassoued, Danielle M. Pastor, Clint T. Allen, Gary L. Gallia, James L. Gulley, James W. Hodge, Nyall R. London
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionCancer stem cells (CSCs), a group of tumor-initiating and tumor-maintaining cells, may be major players in the treatment resistance and recurrence distinctive of chordoma. Characterizing CSCs is crucial to better targeting this subpopulat
Externí odkaz:
https://doaj.org/article/ba6819eb8a42444ebc7cdd19fe5b44dc
Autor:
Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Elizabeth Lamping, Osama Rahma, Houssein Abdul Sater, Jennifer L Marté, Beatriz Walter-Rodriguez, Yulia Vugmeyster, Yo-Ting Tsai, Shania Bailey, Wiem Lassoued, Richy Agajanian, Andrew Weisman, Rena Ito, Masashi Sato, Andreas Machl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Bintrafusp alfa, a first-in-class bifunctional fusion protein targeting transforming growth factor-β (TGF-β) and programmed cell death ligand 1, has demonstrated encouraging efficacy as second-line treatment in patients with non-small ce
Externí odkaz:
https://doaj.org/article/299f4d847daa42ea885a8c75c936bce7
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
The clinical success of immune checkpoint inhibitors (ICIs) has demonstrated the promise and challenges of cancer immunotherapy. There is an unmet need to develop novel cancer therapies that can provide clinical benefit for most patients with solid m
Externí odkaz:
https://doaj.org/article/e8fbab143a674dc7a197a8a86991489d
Autor:
James L Gulley, Ari VanderWalde, Emil Lou, Nishant Gandhi, Heloisa Soares, Charalampos S Floudas, Dara Bracken-Clarke, Harris Krause, Alex Farrell, Minh Phan, Rusha Patel, Nyall London
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/93817049c3694a7eb9203957ba9574a3
Autor:
Renee N Donahue, Jeffrey Schlom, James L Gulley, Julius Strauss, Margaret E Gatti-Mays, Nicole J Toney, Nicholas P Tschernia, Stephanie C Pitts
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9102153e00d245c0a30d750be3091a58